Capsugel’s Lipidex Technology Platform uses advanced liquid-filled technologies and manufacturing facilities can help deliver unique solid oral dosage products to market faster.
Capsugel’s Lipidex Technology Platform uses advanced liquid-filled technologies and manufacturing facilities can help deliver unique solid oral dosage products to market faster.
The Lipidex® Technology Platform provides a full range of lipid-based formulation options based on three components:
Capsugel's Lipidex Technology Platform enables healthcare companies to go to market with a dosage form alternative that consumers prefer and perceive to be faster acting. Lipid-based technologies have been successfully employed to solve many formulation challenges on a specific and tailored basis including low bioavailability, low dose / high potency, API content uniformity, API stabilization, food effect, and others. Our lipid-based dosage forms unique look appeals to consumers and gives your product a noticeable edge, offering an uncommon alternative for over-the-counter (OTC) line extensions or a new way to bring innovation to the generic market. We even offer important technologies such as Abusolve™ that leverages a variety of abuse deterrence approaches tailored for a specific API and formulation.
Utilizing lipid-based technology, Capsugel developed proprietary systems designed to help you meet the challenges of formulating or re-formulating drugs in a liquid-filled format.
Learn more about the features and benefits of Capsugel’s advanced liquid-filled platform including:
Please contact us at DFSinquiry@capsugel.com for further information about the Lipidex® Technology Platform.
NOTE: SGcaps capsules not available in Japan.